Vitamin E added to levothyroxine for people with underactive thyroid
Tests vitamin E alongside levothyroxine in adults with hypothyroidism.
Key facts
- Who runs it
- Bangladesh Medical University
- Where
- Bangladesh1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Vitamin E Add-On Therapy, Thyroid Function & Oxidative Stress in Levothyroxine-Treated Hypothyroidism
- Status
- Enrolling by invitation
- People taking part
- 74 people, planned
- Starts
- Feb 2027
- Expected to end
- Jul 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- vitamin E
- placebo
- Record updated
- 25 August 2026
Who can take part
The trial is looking for adults with hypothyroidism (an underactive thyroid) who take levothyroxine. It tests whether adding vitamin E changes thyroid function and oxidative stress, compared with a placebo (dummy capsule).
- Age
- Above 18 years up to 75 years
- Sex
- Men and women can join.
- Disease stage
- Hypothyroidism treated with levothyroxine.
- Earlier treatment
- People must have been taking Levothyroxine for at least 12 weeks.
- Main reasons for not taking part
- Pregnant or breastfeeding women cannot join.
- People with active cancer cannot join.
- People with known allergy to vitamin E cannot join.
- People taking any other antioxidant drug, or any blood-thinning or antiplatelet drug, cannot join.
- People with acute illness, liver disease, a psychiatric disorder or high blood fats (hyperlipidemia) cannot join.
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- Age above 18 years up to 75 years
- Patient receiving Levothyroxine for at least 12 weeks
- Both male and female patient
Who cannot take part
- Patient taking any other antioxidant drug
- Patients taking any antiplatelet or anticoagulant drug
- Suffering from active malignancy
- Known hypersensitivity to vitamin E
- Patient with acute illness, liver disease, psychiatric disorder, hyperlipidemia
- Pregnancy or lactating mother
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Hypothyroidism
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to learn if vitamin E supplementation as an adjunct to levothyroxine therapy help to reduce oxidative stress, improve antioxidant defence mechanisms, and favourably influence thyroid hormone status, making it a promising therapeutic strategy for patients with hypothyroidism. The findings from this investigation aim to establish an evidence-based framework for integrating targeted antioxidant therapies into standard hypothyroid management strategies.
The 2 groups in the trial
- Vitamin E 400mg, participants received cap vitamin E 400mg orally once daily for 12 weeksTreatment being tested
Vitamin E capsule Alpha tocopherol, capsule, 400mg, 12weeks
Treatment: vitamin E
- participants received vitamin E placebo capsule matching vitamin E capsule orally once dailyPlacebo, for comparison
Vitamin E placebo capsule Capsule, 400mg, 12 weeks
Treatment: placebo
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Vitamin E as add-on Therapy on Thyroid Function and Oxidative Stress in Levothyroxine Treated Hypothyroid Patients: A Randomized, Double-blind, Placebo-controlled Trial
- Plain-language title
- Vitamin E added to levothyroxine for people with underactive thyroidGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT07781514, who can take part
- Record updated
- 25 August 2026